Ancestral antibiotic resistance in Mycobacterium tuberculosis.

Chemotherapeutic options to treat tuberculosis are severely restricted by the intrinsic resistance of Mycobacterium tuberculosis to the majority of clinically applied antibiotics. Such resistance is partially provided by the low permeability of their unique cell envelope. Here we describe a complementary system that coordinates resistance to drugs that have penetrated the envelope, allowing mycobacteria to tolerate diverse classes of antibiotics that inhibit cytoplasmic targets. This system depends on whiB7, a gene that pathogenic Mycobacterium shares with Streptomyces, a phylogenetically related genus known as the source of diverse antibiotics. In M. tuberculosis, whiB7 is induced by subinhibitory concentrations of antibiotics (erythromycin, tetracycline, and streptomycin) and whiB7 null mutants (Streptomyces and Mycobacterium) are hypersusceptible to antibiotics in vitro. M. tuberculosis is also antibiotic sensitive within a monocyte model system. In addition to antibiotics, whiB7 is induced by exposure to fatty acids that pathogenic Mycobacterium species may accumulate internally or encounter within eukaryotic hosts during infection. Gene expression profiling analyses demonstrate that whiB7 transcription determines drug resistance by activating expression of a regulon including genes involved in ribosomal protection and antibiotic efflux. Components of the whiB7 system may serve as attractive targets for the identification of inhibitors that render M. tuberculosis or multidrug-resistant derivatives more antibiotic-sensitive.

[1]  S. Levy,et al.  marA, a regulated locus which controls expression of chromosomal multiple antibiotic resistance in Escherichia coli , 1991, Journal of bacteriology.

[2]  F. Kanetsuna.  Bactericidal Effect of Fatty Acids on Mycobacteria, with Particular Reference to the Suggested Mechanism of Intracellular Killing , 1985, Microbiology and immunology.

[3]  C. Dye,et al.  Consensus statement. Global burden of tuberculosis: estimated incidence, prevalence, and mortality by country. WHO Global Surveillance and Monitoring Project. , 1999, JAMA.

[4]  W. Bishai,et al.  Multiple paralogous genes related to the Streptomyces coelicolor developmental regulatory gene whiB are present in Streptomyces and other actinomycetes. , 2000, Microbiology.

[5]  D. Sherman,et al.  The secret lives of the pathogenic mycobacteria. , 2003, Annual review of microbiology.

[6]  J. Mckinney.  In vivo veritas: The search for TB drug targets goes live , 2000, Nature Medicine.

[7]  C. Thompson,et al.  A Transcriptional Regulator of a Pristinamycin Resistance Gene inStreptomyces coelicolor * , 2001, The Journal of Biological Chemistry.

[8]  A. Steinbüchel,et al.  Triacylglycerols in prokaryotic microorganisms , 2002, Applied Microbiology and Biotechnology.

[9]  Yang Liu,et al.  Transcriptional Adaptation of Mycobacterium tuberculosis within Macrophages , 2003, The Journal of experimental medicine.

[10]  W. Jacobs,et al.  Genetic methods for deciphering virulence determinants of Mycobacterium tuberculosis. , 2002, Methods in enzymology.

[11]  W. Jacobs,et al.  Mycobacterium tuberculosis WhiB3 interacts with RpoV to affect host survival but is dispensable for in vivo growth , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  C. Thompson,et al.  Stress‐activated expression of a Streptomyces pristinaespiralis multidrug resistance gene (ptr) in various Streptomyces spp. and Escherichia coli , 1995, Molecular microbiology.

[13]  C Cambillau,et al.  Cutinase, a lipolytic enzyme with a preformed oxyanion hole. , 1994, Biochemistry.

[14]  A. Tomasz,et al.  Sigma-B, a putative operon encoding alternate sigma factor of Staphylococcus aureus RNA polymerase: molecular cloning and DNA sequencing , 1996, Journal of bacteriology.

[15]  Jiri Vohradsky,et al.  Proteomic studies of diauxic lag in the differentiating prokaryote Streptomyces coelicolor reveal a regulatory network of stress‐induced proteins and central metabolic enzymes , 2003, Molecular microbiology.

[16]  B. Barrell,et al.  Deciphering the biology of Mycobacterium tuberculosis from the complete genome sequence , 1998, Nature.

[17]  T. Kieser.  Practical streptomyces genetics , 2000 .

[18]  P. Arrigo,et al.  The Multidrug Transporters Belonging to Major Facilitator Superfamily (MFS) in Mycobacterium tuberculosis , 2002, Molecular medicine.

[19]  H. Tomioka,et al.  Growth of group IV mycobacteria on medium containing various saturated and unsaturated fatty acids , 1984, Antimicrobial Agents and Chemotherapy.

[20]  W. Bishai,et al.  Mechanisms of latency in Mycobacterium tuberculosis. , 1998, Trends in microbiology.

[21]  C. Thompson,et al.  Thiostrepton-induced gene expression in Streptomyces lividans , 1989, Journal of bacteriology.

[22]  F. Doucet-Populaire,et al.  Natural and acquired macrolide resistance in mycobacteria. , 2002, Current drug targets. Infectious disorders.

[23]  G. Newton,et al.  Mycothiol-Deficient Mycobacterium smegmatis Mutants Are Hypersensitive to Alkylating Agents, Free Radicals, and Antibiotics , 2002, Antimicrobial Agents and Chemotherapy.

[24]  B. Barrell,et al.  Complete genome sequence of the model actinomycete Streptomyces coelicolor A3(2) , 2002, Nature.

[25]  D. Young,et al.  Molecular Cloning and Characterization of Tap, a Putative Multidrug Efflux Pump Present in Mycobacterium fortuitum and Mycobacterium tuberculosis , 1998, Journal of bacteriology.

[26]  Stanley N Cohen,et al.  SOS Response Induction by ß-Lactams and Bacterial Defense Against Antibiotic Lethality , 2004, Science.

[27]  R. Tibshirani,et al.  Significance analysis of microarrays applied to the ionizing radiation response , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Liem Nguyen,et al.  Protein Kinase G from Pathogenic Mycobacteria Promotes Survival Within Macrophages , 2004, Science.

[29]  K. Chater.  Regulation of sporulation in Streptomyces coelicolor A3(2): a checkpoint multiplex? , 2001, Current opinion in microbiology.

[30]  H. Nikaido,et al.  Mycobacterial cell wall: structure and role in natural resistance to antibiotics. , 1994, FEMS microbiology letters.

[31]  J. McClure,et al.  Transcriptional modulation of bacterial gene expression by subinhibitory concentrations of antibiotics , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[32]  W. Bishai,et al.  whmD is an essential mycobacterial gene required for proper septation and cell division. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[33]  C. Nathan.  Antibiotics at the crossroads , 2004, Nature.

[34]  S. Levy,et al.  Differential Expression of over 60 Chromosomal Genes in Escherichia coli by Constitutive Expression of MarA , 2000, Journal of bacteriology.

[35]  F. Doucet-Populaire,et al.  Molecular Basis of Intrinsic Macrolide Resistance in the Mycobacterium tuberculosis Complex , 2004, Antimicrobial Agents and Chemotherapy.

[36]  J. Sun,et al.  Green fluorescent protein as a reporter for spatial and temporal gene expression in Streptomyces coelicolor A3(2). , 1999, Microbiology.

[37]  B. Bloom,et al.  Tuberculosis Pathogenesis, Protection, and Control , 1994 .

[38]  Tuberculosis: Pathogenesis, Protection, and Control , 1994 .

[39]  J Davies,et al.  Inactivation of antibiotics and the dissemination of resistance genes. , 1994, Science.

[40]  W. Bishai,et al.  Evidence That the Streptomyces Developmental Protein WhiD, a Member of the WhiB Family, Binds a [4Fe-4S] Cluster* , 2005, Journal of Biological Chemistry.

[41]  Christopher Dye,et al.  Global Burden of Tuberculosis: Estimated Incidence, Prevalence, and Mortality by Country , 1999 .

[42]  K. Chater,et al.  The Streptomyces coelicolor whiB gene encodes a small transcription factor-like protein dispensable for growth but essential for sporulation , 1992, Molecular and General Genetics MGG.